0.764
price up icon12.35%   0.084
after-market 시간 외 거래: .79 0.026 +3.40%
loading
전일 마감가:
$0.68
열려 있는:
$0.69
하루 거래량:
970.05K
Relative Volume:
0.60
시가총액:
$70.91M
수익:
$153.73M
순이익/손실:
$-106.79M
주가수익비율:
-0.4292
EPS:
-1.78
순현금흐름:
$-115.93M
1주 성능:
-5.13%
1개월 성능:
-15.56%
6개월 성능:
-60.41%
1년 성능:
-74.19%
1일 변동 폭
Value
$0.6875
$0.7916
1주일 범위
Value
$0.6736
$0.84
52주 변동 폭
Value
$0.5231
$5.17

Sutro Biopharma Inc Stock (STRO) Company Profile

Name
명칭
Sutro Biopharma Inc
Name
전화
650-392-8412
Name
주소
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Name
직원
269
Name
트위터
@SutroBio
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
STRO's Discussions on Twitter

STRO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
STRO
Sutro Biopharma Inc
0.764 70.91M 153.73M -106.79M -115.93M -1.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-16 업그레이드 Piper Sandler Neutral → Overweight
2025-03-17 다운그레이드 H.C. Wainwright Buy → Neutral
2025-03-14 다운그레이드 BofA Securities Buy → Underperform
2025-03-14 다운그레이드 Citizens JMP Mkt Outperform → Mkt Perform
2025-03-14 다운그레이드 Wedbush Outperform → Neutral
2024-05-08 개시 BofA Securities Buy
2023-11-09 개시 Deutsche Bank Buy
2023-10-06 개시 Oppenheimer Outperform
2023-03-21 다운그레이드 Wells Fargo Overweight → Equal Weight
2022-08-18 재개 Wells Fargo Overweight
2021-06-18 개시 H.C. Wainwright Buy
2020-12-03 개시 Stifel Buy
2020-09-02 개시 Jefferies Buy
2020-07-16 개시 Wells Fargo Overweight
2020-01-13 개시 SunTrust Buy
2019-10-07 개시 BTIG Research Buy
2019-07-18 개시 Deutsche Bank Buy
2019-04-29 개시 H.C. Wainwright Buy
2018-10-22 개시 JMP Securities Mkt Outperform
2018-10-22 개시 Piper Jaffray Overweight
2018-10-22 개시 Wedbush Outperform
모두보기

Sutro Biopharma Inc 주식(STRO)의 최신 뉴스

pulisher
Jun 17, 2025

Sutro Biopharma (NASDAQ:STRO) Upgraded to Overweight at Piper Sandler - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

Sutro Biopharma (STRO) Receives Upgrade to Overweight by Piper S - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Piper Sandler Upgrades Sutro Biopharma to Overweight From Neutral, $2 Price Target - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

Sutro Biopharma (STRO) Receives Upgrade with Promising Drug Prospects | STRO Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Piper Sandler upgrades Sutro Biopharma stock rating on pipeline progress By Investing.com - Investing.com Canada

Jun 16, 2025
pulisher
Jun 16, 2025

Bank of America Corp DE Sells 22,894 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Jun 16, 2025
pulisher
Jun 16, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Given Consensus Rating of “Hold” by Analysts - Defense World

Jun 16, 2025
pulisher
Jun 15, 2025

Piper Sandler Upgrades Sutro Biopharma (STRO) to Overweight | ST - GuruFocus

Jun 15, 2025
pulisher
Jun 09, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Stock Position Decreased by Two Sigma Investments LP - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Sold by Millennium Management LLC - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

ProShare Advisors LLC Boosts Holdings in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Jun 05, 2025
pulisher
Jun 03, 2025

Nuveen Asset Management LLC Acquires 124,154 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Sutro Biopharma names Greg Chow as new CFO - Investing.com

Jun 03, 2025
pulisher
Jun 02, 2025

Sutro Biopharma (STRO) Appoints New CFO Greg Chow | STRO Stock N - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Sutro Biopharma names Greg Chow as new CFO By Investing.com - Investing.com Canada

Jun 02, 2025
pulisher
Jun 02, 2025

Sutro Biopharma Appoints Greg Chow as Chief Financial Officer - The Manila Times

Jun 02, 2025
pulisher
Jun 02, 2025

Sutro Biopharma Strengthens ADC Leadership: New CFO Brings $225M Capital Raising Track Record - Stock Titan

Jun 02, 2025
pulisher
Jun 02, 2025

Two Sigma Advisers LP Has $1.01 Million Stock Holdings in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Jun 02, 2025
pulisher
May 29, 2025

Northern Trust Corp Buys 14,492 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

May 29, 2025
pulisher
May 28, 2025

BNP Paribas Financial Markets Buys 68,234 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

May 28, 2025
pulisher
May 27, 2025

Sutro Biopharma’s SWOT analysis: stock shifts focus amid pipeline changes By Investing.com - Investing.com Nigeria

May 27, 2025
pulisher
May 26, 2025

Sutro Biopharma’s SWOT analysis: stock shifts focus amid pipeline changes - Investing.com

May 26, 2025
pulisher
May 23, 2025

Sutro Biopharma unveils best-in-class anti-tissue factor ADC - BioWorld MedTech

May 23, 2025
pulisher
May 22, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Given Consensus Rating of “Hold” by Brokerages - Defense World

May 22, 2025
pulisher
May 20, 2025

Sutro Biopharma (NASDAQ:STRO) Price Target Cut to $0.80 by Analysts at Bank of America - Defense World

May 20, 2025
pulisher
May 19, 2025

Sutro Biopharma (STRO): Analyst Lowers Price Target by 20% | STR - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Bank of America Adjusts Sutro Biopharma (STRO) Price Target | ST - GuruFocus

May 19, 2025
pulisher
May 15, 2025

Dimensional Fund Advisors LP Buys 156,139 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

May 15, 2025
pulisher
May 14, 2025

Sutro Biopharma Reports Q1 2025 Earnings and Restructuring - TipRanks

May 14, 2025
pulisher
May 14, 2025

Transcript : Sutro Biopharma, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 04 - marketscreener.com

May 14, 2025
pulisher
May 12, 2025

Sutro Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Sold by Barclays PLC - Defense World

May 12, 2025
pulisher
May 10, 2025

Sutro Biopharma Inc Reports Q1 2025 Revenue of $17.4M, Exceeding Estimates; EPS at -$0.91, Missing Projections - GuruFocus

May 10, 2025
pulisher
May 10, 2025

Sutro Biopharma First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

May 10, 2025
pulisher
May 09, 2025

Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates - NewsBreak: Local News & Alerts

May 09, 2025
pulisher
May 09, 2025

Sutro Biopharma earnings missed by $0.06, revenue topped estimates - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights - The Manila Times

May 09, 2025
pulisher
May 08, 2025

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights | STRO Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Sutro Biopharma, Inc. Advances ADC Pipeline Focus with Promising Preclinical Results and Strategic Reprioritization - Nasdaq

May 08, 2025
pulisher
May 07, 2025

Financial Metrics Check: Sutro Biopharma Inc (STRO)’s Ratios for Trailing Twelve Months - DWinneX

May 07, 2025
pulisher
May 06, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Bought by Invesco Ltd. - Defense World

May 06, 2025
pulisher
May 02, 2025

Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail

May 02, 2025
pulisher
May 02, 2025

Sutro Biopharma (NASDAQ:STRO) Earns Neutral Rating from HC Wainwright - The AM Reporter

May 02, 2025
pulisher
May 01, 2025

Sutro Biopharma to Participate in Upcoming Investor Conferences - The Manila Times

May 01, 2025
pulisher
May 01, 2025

Leading ADC Developer Sutro Biopharma to Present at Citizens and BofA Healthcare Conferences in May - Stock Titan

May 01, 2025
pulisher
May 01, 2025

New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty - Benzinga

May 01, 2025
pulisher
May 01, 2025

Sutro Biopharma (NASDAQ:STRO) Earns “Neutral” Rating from HC Wainwright - Defense World

May 01, 2025
pulisher
Apr 30, 2025

Taking the lead: Sutro Biopharma Inc (STRO) - Sete News

Apr 30, 2025

Sutro Biopharma Inc (STRO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Sutro Biopharma Inc 주식 (STRO) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
FITZPATRICK LINDA A
CHIEF PEOPLE & COMM. OFFICER
May 01 '25
Option Exercise
0.00
37,849
0
133,282
Srinivasan Venkatesh
CHIEF TECH OP OFFICER
May 01 '25
Option Exercise
0.00
2,500
0
54,580
Borgman Anne Elizabeth
CHIEF MEDICAL OFFICER
May 01 '25
Option Exercise
0.00
69,063
0
122,161
Srinivasan Venkatesh
CHIEF TECH OP OFFICER
Apr 11 '25
Option Exercise
0.00
21,250
0
59,683
NEWELL WILLIAM J
CEO
Mar 05 '25
Option Exercise
0.00
18,750
0
299,239
FITZPATRICK LINDA A
CHIEF PEOPLE & COMM. OFFICER
Mar 05 '25
Option Exercise
0.00
8,750
0
99,027
ALBINI EDWARD C
CFO AND SECRETARY
Mar 05 '25
Option Exercise
0.00
8,750
0
135,675
FITZPATRICK LINDA A
CHIEF PEOPLE & COMM. OFFICER
Mar 04 '25
Option Exercise
0.00
9,125
0
94,025
NEWELL WILLIAM J
CEO
Mar 04 '25
Option Exercise
0.00
31,125
0
291,625
Chung Jane
PRESIDENT AND COO
Mar 04 '25
Option Exercise
0.00
7,875
0
100,642
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):